欧美亚洲国内精品bt,欧美激情精品久久久久久蜜臀,欧美a级免费黄片视频,久久一区二区三区精品

當(dāng)前位置:首頁(yè)  >  技術(shù)文章  >  EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤(rùn)相關(guān)

EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤(rùn)相關(guān)

更新時(shí)間:2024-12-28  |  點(diǎn)擊率:197

20231月,汕頭大學(xué)醫(yī)學(xué)院第二附屬醫(yī)院泌尿外科;廣州醫(yī)科大學(xué)第五附屬醫(yī)院泌尿外科;中山大學(xué)第一附屬醫(yī)院泌尿外科 (Department of Urology, The Second Affiliated Hospital of Shantou University, Medical College,Shantou 515041, ChinaDepartment of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, China;Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China) Hao Lin老師研究團(tuán)隊(duì)在《Cancers》上發(fā)表論文:

EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer"

 

EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤(rùn)相關(guān)"

 

Abstract

Purpose: To assess the mechanism of EPH receptor A3 (EPHA3) and its potential value for immunotherapy in BLCA.

Materials and methods: The Cancer Genome Atlas (TCGA) bladder cancer (BLCA) database and the Gene Expression Omnibus (GEO) database were used for assessing whether EHPA3 could be used to predict BLCA prognosis. This work carried out in vitro and in vivo assays for exploring how EPHA3 affected the biological behaviors. The downstream pathway was explored using a Western blotting technique. The CIBERSORT, ESTIMATE, TIMER, and TIDE tools were used to predict the immunotherapy value of EPHA3 in BLCA.

Results: EPHA3 was poorly expressed in BLCA (p < 0.05), its high expression is related to a good survival prognosis (p = 0.027 and p = 0.0275), and it has a good predictive ability for the histologic grade and status of BLCA (area under curve = 0.787 and 0.904). Overexpressed EPHA3 could inhibit BLCA cell biological behaviors, and it be associated with the downregulation of the Ras/pERK1/2 pathway. EPHA3 was correlated with several immune-infiltrating cells and the corresponding marker genes.

Conclusions: EPHA3 could be regarded as an acceptable anti-cancer biomarker in BLCA. EPHA3 plays an inhibiting role in BLCA, and it could be the candidate immunotherapeutic target for BLCA.


摘要:

目的:探討EPH受體A3 (EPHA3)的作用機(jī)制及其在BLCA免疫治療中的潛在價(jià)值。材料與方法:采用Cancer Genome Atlas (TCGA)膀胱癌(BLCA)數(shù)據(jù)庫(kù)和Gene Expression Omnibus (GEO)數(shù)據(jù)庫(kù)評(píng)估EHPA3是否可用于預(yù)測(cè)BLCA預(yù)后。本工作通過(guò)體外和體內(nèi)實(shí)驗(yàn)探討EPHA3對(duì)生物行為的影響。使用Western blotting技術(shù)探索下游途徑。采用CIBERSORT、ESTIMATETIMERTIDE工具預(yù)測(cè)EPHA3BLCA中的免疫治療價(jià)值。結(jié)果:EPHA3BLCA中表達(dá)較低(p < 0.05),其高表達(dá)與較好的生存預(yù)后相關(guān)(p = 0.027p = 0.0275),對(duì)BLCA的組織學(xué)分級(jí)和狀態(tài)有較好的預(yù)測(cè)能力(曲線下面積分別為0.7870.904)。EPHA3過(guò)表達(dá)可抑制BLCA細(xì)胞的生物學(xué)行為,并與Ras/pERK1/2通路下調(diào)有關(guān)。EPHA3與多種免疫浸潤(rùn)細(xì)胞及相應(yīng)的標(biāo)記基因相關(guān)。結(jié)論:EPHA3可作為BLCA的一種可接受的抗癌生物標(biāo)志物。EPHA3BLCA中具有抑制作用,可能成為BLCA的候選免疫治療靶點(diǎn)。

 

該論文中,人類膀胱癌細(xì)胞(5637、UMUC-3T24)以及正常的人類尿上皮細(xì)胞(SVHUC)的體外培養(yǎng)是使用Ausbian特級(jí)胎牛血清完成的。


久久99国产中文| 中文国产成人精品久久久| 男女真人牲交高潮全过程| 欧美亚洲熟妇视频在线观看| 91热国产在线观看| 骚货 淫水 国产| 国产情侣色综合久久有码| 亚洲狠狠插狠狠搞狠狠摸| 被春药女高潮抽搐喷水视频| 性爱大鸡吧喷水视频| 日韩激情视频在线看免费| 美女荒郊野外找男人靠逼| 久久精品人人爽人人爽快| 国产色哟哟精选在线播放| 日本高清一区二区三区不卡| 最新日本一区二区三区免费看| 久久99国产中文| 国产 欧美 日韩 黄片| 日韩欧美中文字幕国产精品| 中文字幕精品字幕一区二区三区| 亚洲女同一区二区三久久精品| 在线视频观看一区| 白丝袜子宫啊啊啊不要了| 午夜场射精嗯嗯啊啊视频| 久久综合色鬼综合色| 美女让我插她的骚逼| 在线 中文字幕 第一页| 美女日逼视频免费| 尤物网三级在线观看| 日本成人在线一区中文字幕| 欧美大鸡巴操穴日韩| 亚洲国产综合精品 在线 一区| 亚洲激情无码视频| 欧美一区二区三区久久国产精品| 精品一区二区三区乱码中文字幕| 被公侵犯中文字幕在线观看| 美女荒郊野外找男人靠逼| 久久精品国产亚洲av伦理| 国产乱理伦片在线观看夜| 亚洲av一区二区在线看| av日韩在线观看一区二区三区|